Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Report Summary

GlobalData’s new report, “Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the Netherlands Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for  Diabetes Care Devices  market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Netherlands Diabetes Care Devicesmarket.        
• Key players covered include F. Hoffmann-La Roche Ltd., Medtronic, Inc., Sanofi, LifeScan, Inc., Novo Nordisk A/S, Eli Lilly and Company  and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Netherlands Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7

2 Introduction 9
2.1 What is This Report About? 9

3 Diabetes Care Devices In Netherlands 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, 2003-2017 11
3.3 Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2010 12
3.4 Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2010 13
3.5 Diabetes Care Devices, Netherlands, Category Volume (Units), 2003-2017 19
3.6 Diabetes Care Devices, Netherlands, Company Share (2009-2010) 23

4 Glucose Monitoring In Netherlands 25
4.1 Glucose Monitoring, Market Segmentation 25
4.2 Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2010 26
4.3 Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2010 27
4.4 Glucose Monitoring Overall Revenue (2003-2017) 28
4.4.1 Blood Glucose Meters Revenue (2003-2017) 32
4.5 Glucose Monitoring Overall Volume (2003-2017) 36
4.5.1 Blood Glucose Meters Volume (2003-2017) 39
4.6 Glucose Monitoring Average Price (2003-2017) 42
4.7 Glucose Monitoring Distribution Share (2009-2010) 43
4.8 Glucose Monitoring, Netherlands, Company Share (2009-2010) 44

5 Insulin Delivery In Netherlands 46
5.1 Insulin Delivery, Market Segmentation 46
5.2 Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2010 47
5.3 Insulin Delivery Market, Netherlands, Segment Contribution (%), 2010 48
5.4 Insulin Delivery Overall Revenue (2003-2017) 49
5.4.1 Insulin Pens Revenue (2003-2017) 53
5.4.2 Insulin Pumps Revenue (2003-2017) 57
5.5 Insulin Delivery Overall Volume (2003-2017) 60
5.5.1 Insulin Pens Volume (2003-2017) 64
5.5.2 Insulin Pumps Volume (2003-2017) 67
5.6 Insulin Delivery Average Price (2003-2017) 69
5.7 Insulin Delivery Distribution Share (2009-2010) 70
5.8 Insulin Delivery, Netherlands, Company Share (2009-2010) 71

6 Overview of Key Companies in Netherlands Diabetes Care Devices Market 73
6.1 F. Hoffmann-La Roche Ltd. 73
6.1.1 Company Overview 73
6.1.2 Share in the Netherlands Diabetes Care Devices Market 73
6.2 Medtronic, Inc. 74
6.2.1 Company Overview 74
6.2.2 Share in the Netherlands Diabetes Care Devices Market 74
6.3 Sanofi 75
6.3.1 Company Overview 75
6.3.2 Share in the Netherlands Diabetes Care Devices Market 75
6.4 LifeScan, Inc. 76
6.4.1 Company Overview 76
6.4.2 Share in the Netherlands Diabetes Care Devices Market 76
6.5 Novo Nordisk A/S 77
6.5.1 Company Overview 77
6.5.2 Share in the Netherlands Diabetes Care Devices Market 77
6.6 Eli Lilly and Company 78
6.6.1 Company Overview 78
6.6.2 Share in the Netherlands Diabetes Care Devices Market 78
6.7 Abbott Laboratories 79
6.7.1 Company Overview 79
6.8 Bayer HealthCare AG 79
6.8.1 Company Overview 79
6.9 A. Menarini Diagnostics S.r.l. 79
6.9.1 Company Overview 79
6.10 Becton, Dickinson and Company 80
6.10.1 Company Overview 80
6.11 ARKRAY, Inc. 80
6.11.1 Company Overview 80
6.12 Ypsomed Holding AG 80
6.12.1 Company Overview 80
6.13 NIPRO CORPORATION 80
6.13.1 Company Overview 80
6.14 Terumo Corporation 81
6.14.1 Company Overview 81

7 Diabetes Care Devices Market Pipeline Products 82

8 Financial Deals Landscape 86
8.1 Acquisition 86
8.1.1 Mediq Acquires PBG From Mentha Capital 86
8.2 Partnerships 87
8.2.1 Trinity Biotech Enters Into Distribution Agreement with A. Menarini Diagnostics 87
8.2.2 EyeSense Enters Into An Agreement with QIAGEN 88

9 Appendix 89
9.1 Definitions of Markets Covered in the Report 90
9.1.1 Diabetes Care Devices 90
9.2 Research Methodology 94
9.3 Secondary Research 94
9.4 Primary Research 95
9.5 Models 95
9.6 Forecasts 96
9.7 Expert Panels 96
9.8 GlobalData Consulting 96
9.9 Currency Conversion 97
9.10 Contact Us 97
9.11 Disclaimer 97

List of Tables

Table 1:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, 2003-2017 11
Table 2:Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2010 13
Table 3:Diabetes Care Devices, Netherlands, Cross-Segment Analysis, 2003-2017 14
Table 4:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, Historic, 2003-2010 16
Table 5:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 18
Table 6:Diabetes Care Devices, Netherlands, Category Volume (Units), 2003-2017 19
Table 7:Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2003-2010 21
Table 8:Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2010-2017 22
Table 9:Diabetes Care Devices, Netherlands, Company Share by Revenue ($m), USD Actual, 2009-2010 24
Table 10:Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2010 27
Table 11:Glucose Monitoring, Netherlands, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 29
Table 12:Glucose Monitoring, Netherlands, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 31
Table 13:Blood Glucose Meters, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 33
Table 14:Blood Glucose Meters, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 35
Table 15:Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 37
Table 16:Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 38
Table 17:Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 40
Table 18:Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 41
Table 19:Glucose Monitoring, Netherlands, Average Price ($), Historic, 2003-2010 42
Table 20:Glucose Monitoring, Netherlands, Average Price ($), Forecast, 2010-2017 42
Table 21:Glucose Monitoring, Netherlands, Distribution Share by Revenue ($m), USD Actual, 2009-2010 43
Table 22:Glucose Monitoring, Netherlands, Company Share by Revenue ($m), USD Actual 2009-2010 45
Table 23:Insulin Delivery Market, Netherlands, Segment Contribution (%), 2010 48
Table 24:Insulin Delivery, Netherlands, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 50
Table 25:Insulin Delivery, Netherlands, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 52
Table 26:Insulin Pens, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 54
Table 27:Insulin Pens, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 56
Table 28:Insulin Pumps (Traditional Insulin Pumps), Netherlands, Revenue ($m), USD Actual, Historic, 2003-2010 57
Table 29:Insulin Pumps, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 59
Table 30:Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 61
Table 31:Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 63
Table 32:Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 65
Table 33:Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66
Table 34:Insulin Pumps (Traditional Insulin Pumps), Netherlands, Volume (Units), Historic, 2003-2010 67
Table 35:Insulin Pumps Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Table 36:Insulin Delivery, Netherlands, Average Price ($), Historic, 2003-2010 69
Table 37:Insulin Delivery, Netherlands, Average Price ($), Forecast, 2010-2017 69
Table 38:Insulin Delivery, Netherlands, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70
Table 39:Insulin Delivery, Netherlands, Company Share by Revenue ($m), USD Actual 2009-2010 72
Table 40:Diabetes Care Devices Market Pipeline Products 82
Table 41:Mediq Acquires PBG From Mentha Capital 86
Table 42:Trinity Biotech Enters Into Distribution Agreement with A. Menarini Diagnostics 87
Table 43:EyeSense Enters Into An Agreement with QIAGEN 88
Table 44: USD to Local Currency, Netherlands, Average Actual Rate 2003-2010 97

List of Figures

Figure 1:Diabetes Care Devices, Market Segmentation 10
Figure 2:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, 2003-2017 11
Figure 3:Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2010 12
Figure 4:Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2010 13
Figure 5:Diabetes Care Devices, Netherlands, Cross-Segment Analysis, 2003-2017 14
Figure 6:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, Historic, 2003-2010 15
Figure 7:Diabetes Care Devices, Netherlands, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 17
Figure 8:Diabetes Care Devices, Netherlands, Category Volume (Units), 2003-2017 19
Figure 9:Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2003-2010 20
Figure 10:Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2010-2017 22
Figure 11:Diabetes Care Devices, Netherlands, Company Share (%), 2010 23
Figure 12:Glucose Monitoring, Market Segmentation 25
Figure 13:Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2010 26
Figure 14:Glucose Monitoring Market, Netherlands, Segment Contribution (%), 2010 27
Figure 15:Glucose Monitoring, Netherlands, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 28
Figure 16:Glucose Monitoring, Netherlands, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 30
Figure 17:Blood Glucose Meters, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 32
Figure 18:Blood Glucose Meters, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 34
Figure 19:Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 20:Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 21:Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 39
Figure 22:Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 41
Figure 23:Glucose Monitoring, Netherlands, Company Share (%), 2010 44
Figure 24:Insulin Delivery, Market Segmentation 46
Figure 25:Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2010 47
Figure 26:Insulin Delivery Market, Netherlands, Segment Contribution (%), 2010 48
Figure 27:Insulin Delivery, Netherlands, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 49
Figure 28:Insulin Delivery, Netherlands, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 51
Figure 29:Insulin Pens, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 53
Figure 30:Insulin Pens, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 55
Figure 31:Insulin Pumps (Traditional Insulin Pumps), Netherlands, Revenue ($m), USD Actual, Historic, 2003-2010 57
Figure 32:Insulin Pumps, Netherlands, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 58
Figure 33:Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2003-2010 60
Figure 34:Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2010-2017 62
Figure 35:Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Figure 36:Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66
Figure 37:Insulin Pumps (Traditional Insulin Pumps), Netherlands, Volume (Units), Historic, 2003-2010 67
Figure 38:Insulin Pumps Netherlands, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 39:Insulin Delivery, Netherlands, Company Share (%), 2010 71
Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),Netherlands Diabetes Care Devices Market, 2010 73
Figure 41:Medtronic, Inc., Company Share (%),Netherlands Diabetes Care Devices Market, 2010 74
Figure 42:Sanofi, Company Share (%),Netherlands Diabetes Care Devices Market, 2010 75
Figure 43:LifeScan, Inc., Company Share (%),Netherlands Diabetes Care Devices Market, 2010 76
Figure 44:Novo Nordisk A/S, Company Share (%),Netherlands Diabetes Care Devices Market, 2010 77
Figure 45:Eli Lilly and Company, Company Share (%),Netherlands Diabetes Care Devices Market, 2010 78